Advances in the management of metastatic breast cancer: options beyond first-line chemotherapy

Por Ayoub, J.P.M., Verma, Sh., Verma, Su.
Publicado em 2012

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer

Por Dent, S., Verma, Sh., Latreille, J., Rayson, D., Clemons, M., Mackey, J., Verma, Su., Lemieux, J., Provencher, L., Chia, S., Wang, B., Pritchard, K.
Publicado em 2009

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers

Por Lemieux, J., Clemons, M., Provencher, L., Dent, S., Latreille, J., Mackey, J., Pritchard, K.I., Rayson, D., Verma, Sh., Verma, Su., Wang, B., Chia, S.
Publicado em 2009

Optimizing the management of her2-positive early breast cancer: the clinical reality

Por Verma, Su., Lavasani, S., Mackey, J., Pritchard, K., Clemons, M., Dent, S., Latreille, J., Lemieux, J., Provencher, L., Verma, Sh., Chia, S., Wang, B., Rayson, D.
Publicado em 2010